Adult Subjects With Non-Segmental Vitiligo
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adult Subjects With Non-Segmental Vitiligo trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Adult Subjects With Non-Segmental Vitiligo trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a randomized, double-blind, multicenter, placebo-controlled clinical study intended to evaluate the efficacy, safety and population pharmacokinetic prof…
To evaluate the efficacy of QY201 Tablets in adult subjects with non-segmental vitiligo, and to provide evidence for dose selection in the confirmatory Phase II…
Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to evaluate h…
Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to evaluate h…